CEO & Co-Founder

twoXAR Pharmaceuticals

Prior to co-founding twoXAR, Andrew held Chief Technology Officer roles at several early stage companies where he managed teams as large as a hundred technologists distributed around the world. Andrew developed the company’s proprietary algorithm and as Chief Executive Officer is focused on overall company strategy, product development and fundraising. Andrew studied biomedical informatics in Stanford University’s SCPD graduate program and holds Master of Science and Bachelor of Science degrees in Computer Science from Rochester Institute of Technology.


DAY 1 / ‏‏‎ ‎

09:00 AM - 09:40 AM
Plenary View Session

Executive Viewpoints Debate: What Will it Take to Make the Use of AI/ML Tools Scalable?

  • How do you translate AI/ML technology into patient impact
    • Better treatments
    • Higher quality outcomes
    • Less adverse effect
  • Streamlining processes enterprise-wide
Dimitris K. Agrafiotis, PhD, Chief Information Officer, Novartis Institutes for BioMedical Research (NIBR)
Niven R. Narain, Ph.D, Co-Founder, President & CEO, BERG
Andrew Radin, CEO & Co-Founder, twoXAR Pharmaceuticals

Never miss an announcement

/* */